In all countries, unit costs and/or resource use are amongst the two most important causes of between country differences in cost-benefit at low thresholds.
In response to complaints, the insurance superintendent, Neil D. Levin, has ordered all life insurers to document the kinds of policies they carry on New Yorkers, how premiums were calculated, how and where policies were sold and whether there are differences in costs or benefits for minority policyholders compared with white ones.
This variation is most likely due to interspecific differences in costs and benefits of mate-guarding.
Differences in costs and benefits have been identified, measured and valued in the construction of the template.
Consideration of cost-effectiveness for any intervention or policy change requires an incremental approach, where the focus of analysis is on the joint estimation of the differences in costs and benefits between the new process (in this case, phase 3 following the implementation of subgrouping for targeted treatment systems) and the standard process (phase 1).
OEMs buy-in (cost-benefit) 10.
The substantial differences in cost sharing, with otherwise identical benefit provisions, present an opportunity to assess how well the LIS program has achieved its goal of improved access to medications for low-income beneficiaries.
These variables can intuitively be grouped in a total of nine transferability factors, which could potentially cause differences in the cost-benefit of smoking cessation support between countries.
Holding down costs leaves more money in your account growing for your benefit; even small differences in cost, over years of investing, can make a huge difference in your final account balance.
In this evaluation, we also analyzed the group of subjects treated with pregabalin in a subanalysis comparing pregabalin in monotherapy versus pregabalin as an addon therapy, with the aim of determining whether a difference in cost or health benefit exists between these two treatment populations at baseline and at end-of-trial.
This is partly because of the complexity of trying to forecast the main outcome of interest to economists the joint distribution of the difference in costs and benefits between treatment arms.
